Work

Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor

Year: 2019

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2019.02.018

Authors: Kamal Ahmed, Alexey Koval, Jiabin Xu, Alexandre Bodmer, Vladimir L. Katanaev

Institutions: University of Lausanne, University of Geneva, University Hospital of Geneva, Far Eastern Federal University

Language: English

Topic: Wnt/β-catenin signaling in development and cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Novartis Foundation, Krebsliga Schweiz, Novartis Stiftung für Medizinisch-Biologische Forschung

Awards: G4598326120, G6608132051

OpenAlex ID: W2911905836

FWCI: 2.71

Cites: 69

Cited by: 69

Related to: 10